LQDA

Liquidia Corporation Common Stock · XNAS · 131 sessions on record

$30.26▼ −40.43 · −57.2%from $70.69 the session before · Sep 30, 2026 close · end of day

Open: $70.54
High: $71.93
Low: $29.86
Day's range: $4260% of the previous close
VWAP: $36.83close −18% from it
Volume, shares: 23M18.39× the 20-session average
Traded, $: $845.3M
Trades: 188K120 shares per trade
Previous close: $70.69−40.43 to the close
Market cap: $2.71Bat the close of Sep 30

Day range1% of the way up

$29.86$71.93

52-week range1% of the way up

$29.86 Sep 30$93.61 Aug 11

−68% from the high · +1.3% from the low

Options

No listed options on LQDA

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

131 sessions on file · from Mar 25

LQDA close
S&P 500, rebased

Session read · latest close: Sep 30, 2026
Close $ · day %: $30.26▼ −57.2% on the previous close
Against S&P 500: S&P 500 −0.2%−57.0 pp difference on the day
Against the averages: below 20 · below 5020-session $66.48 (−54%) · 50-session $74.36 (−59%)
Volume: 18.39×the previous 20 sessions · 23M shares
Extremes on the day: lowest close in 250 sessions

Quarterly results

consolidated · latest filed Aug 12, 2026 · SEC filings

Revenue $171.7M, +1,800% on a year earlier; profit $74.7M in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session

Quarterly results of LQDA on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue $	Revenue YoY	Profit $	Profit YoY	EPS $	Market on the day
Jun 2026filed Aug 12	$171.7M	▲ +1,800%	$74.7M	—	0.74	▼ −8.5%S&P 500 +0.7% · −9.2 pp
Mar 2026filed Aug 12	$132.9M	▲ +4,200%	$52.9M	—	0.52	▼ −8.5%S&P 500 +0.7% · −9.2 pp
Dec 2025filed Mar 5	$92.0M	▲ +3,100%	$14.6M	—	0.18	—not reached
Sep 2025filed Nov 3	$54.3M	▲ +1,100%	−$3.5M	—	-0.04	—not reached
Jun 2025filed Aug 12	$8.8M	▲ +140%	−$41.6M	—	-0.49	▼ −8.5%S&P 500 +0.7% · −9.2 pp
Mar 2025filed Aug 12	$3.1M	▲ +5.0%	−$38.4M	—	-0.45	▼ −8.5%S&P 500 +0.7% · −9.2 pp
Dec 2024filed Mar 19	$2.9M	▼ −36%	−$40.6M	—	-0.48	—not reached
Sep 2024filed Nov 3	$4.4M	▲ +21%	−$31.0M	—	-0.40	—not reached

By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends

Financial-year results of LQDA on the consolidated basis, summed from the quarters filed
Year	Revenue $	Revenue YoY	Profit $	Profit YoY	EPS $
FY25to Dec 2025	$158.3M	▲ +1,000%	−$68.9M	—	-0.80
FY24to Dec 2024	$14.0M	▼ −20%	−$128.3M	—	-1.63
FY23to Dec 2023	$17.5M	▲ +9.8%	−$78.5M	—	-1.21
FY22to Dec 2022	$15.9M	▲ +24%	−$41.0M	—	-0.67
FY21to Dec 2021	$12.9M	▲ +1,600%	−$34.6M	—	-0.70

Fundamentals

consolidated · filings to Jun 2026 · close $30.26 on Sep 30

LQDA trades at 22 times trailing earnings against 20 for its industry, 14 times book value, revenue +2,200% over twelve months, market cap $2.71B.

Valuation

Market cap: $2.71Bon Sep 30
Price to earnings: 22consolidated · four quarters to Jun 2026 · industry 20
Trailing EPS: $1.40diluted · consolidated · four quarters to Jun 2026
Price to book: 14consolidated · balance sheet to Jun 2026
Book value a share: $2.18consolidated · balance sheet to Jun 2026
Debt to equity: —
Return on equity: 130%trailing profit over average equity · consolidated
Dividend yield: —
Price to sales: 6.0market cap over revenue, four quarters to Jun 2026
Shares outstanding: 89.5Mon Sep 30

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: $450.9Mfour quarters to Jun 2026
Revenue growth, 12 months: ▲ +2,200%against the twelve months before
Revenue 3-year CAGR: ▲ +190%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months: $138.6Mfour quarters to Jun 2026
Profit growth, 12 months: —
Profit 3-year CAGR: —

PeersPharmaceutical Preparations · the ten largest by market cap · industry P/E 20, market caps over trailing profit of 6 stocks

Stocks in the industry Pharmaceutical Preparations with market cap, price to earnings and price to book
Stock	Market cap	P/E	P/B	Close $
REGNRegeneron Pharmaceuticals Inc	$71.24Bon Sep 30	19consolidated	2.3	$758.27
UTHRUnited Therapeutics Corp	$23.24Bon Sep 30	19consolidated	3.6	$541.89
RPRXRoyalty Pharma plc Class A Ordinary Shares	$22.65Bon Sep 30	31consolidated	—	$58.36
BMRNBioMarin Pharmaceuticals Inc	$11.61Bon Sep 30	150consolidated	1.8	$60.00
LQDALiquidia Corporation Common Stock	$2.71Bon Sep 30	22consolidated	14	$30.26
ANIPANI Pharmaceuticals, Inc.	$1.77Bon Sep 30	16consolidated	3.0	$72.65
STOKStoke Therapeutics, Inc. Common Stock	$1.68Bon Sep 30	—	4.9	$26.00
MLTXMoonLake Immunotherapeutics Class A Ordinary Shares	$995.7Mon Sep 30	—	2.3	$11.70
JBIOJade Biosciences, Inc. Common Stock	$893.5Mon Sep 30	1.7consolidated	2.0	$14.05
CLYMClimb Bio, Inc. Common Stock	$658.8Mon Sep 30	—	2.8	$11.47

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 160% of shares, BlackRock, Inc. the largest at 24%, FARALLON CAPITAL MANAGEMENT LLC 19% and Caligan Partners LP 18%, as filed for the quarter to Jun 2026.

24.1%18.7%18.1%97.1%

Held by 13F managers: 160%of shares outstanding
Shares held: 141M+12% on Mar 2026 among managers filing both
Managers holding: 307230 a quarter earlier
Largest holder: 24%BlackRock, Inc.

Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter

Largest 13F holders of LQDA
Manager	Shares	Of outstanding	Value	Change on quarter
BlackRock, Inc.	21.6M	24%	$1.72B	+10.6M
FARALLON CAPITAL MANAGEMENT LLC	16.7M	19%	$1.33B	−582K
Caligan Partners LP	16.2M	18%	$1.29B	unchanged
FINDELL CAPITAL MANAGEMENT LLC	7M	7.8%	$558.4M	unchanged
VANGUARD CAPITAL MANAGEMENT LLC	6.28M	7.0%	$500.6M	+424K
STATE STREET CORP	6.06M	6.8%	$483.2M	+2.3M
Opaleye Management Inc.	4.9M	5.5%	$390.3M	−195K
GEODE CAPITAL MANAGEMENT, LLC	4.24M	4.7%	$338.3M	+385K
BANK OF AMERICA CORP /DE/	3.98M	4.5%	$317.6M	−592K
VANGUARD PORTFOLIO MANAGEMENT LLC	3.06M	3.4%	$244.3M	+1.8M

Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

LQDA insider trades
Insider	Trade	Shares	Price	Held after
Bloch Stephen MDirector	sold · Jun 22, 2026	69,500	$75.54	910,573
Bloch Stephen MDirector	sold · Jun 22, 2026	30,500	$76.18	880,073
Caligan Partners LPDirector,TenPercentOwner,Other	granted · Jun 16, 2026	5,882	$0.00	5,882
Rielly-Gauvin KatherineDirector	granted · Jun 16, 2026	5,882	$0.00	44,637
KIRSCH ARTHUR SDirector	granted · Jun 16, 2026	5,882	$0.00	46,637
Horobin JoannaDirector	granted · Jun 16, 2026	5,882	$0.00	39,637
deGoa DamianDirector	granted · Jun 16, 2026	5,882	$0.00	92,353
Bloch Stephen MDirector	granted · Jun 16, 2026	5,882	$0.00	71,594
SINGH RAMANDirector	granted · Jun 16, 2026	5,882	$0.00	44,637
Manning Paul BDirector	granted · Jun 16, 2026	5,882	$0.00	475,465

Corporate actions

exchange records

No corporate action on record for LQDA yet.

Price history

131 sessions on record · to Sep 30 · end of day

LQDA is −54.8% over 20 sessions against the S&P 500's +0.1%, 68% below its 52-week high, realised volatility 310% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions

Returns of the stock and S&P 500 over six windows, longest first
Window	From $	LQDA %	S&P 500 %	Difference pp
120 sessionssince Apr 9	$40.32	▼ −25%	▲ +12%	−37
60 sessionssince Jul 7	$81.23	▼ −63%	▲ +2.0%	−65
20 sessionssince Sep 1	$66.92	▼ −55%	▲ +0.11%	−55
5 sessionssince Sep 23	$67.48	▼ −55%	▼ −0.67%	−54
1 sessionsince Sep 29	$70.68	▼ −57%	▼ −0.21%	−57

Averages of the closeclose against each average

5-session average: $62.80close −52% from it
20-session average: $66.48close −54% from it
50-session average: $74.36close −59% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: $6.221% of the close
Average day's range, 20: $2.27.3% of the close
Volume against 20 sessions: 18.39×23M vs 2.33M average

Volatility and co-movement with S&P 500annualised from daily returns

Realised volatility, 20: 310%≈ ±19% a session · moved more than that on 1 of 20
Realised volatility, 60: 180%≈ ±12% a session · moved more than that on 1 of 60
Beta to S&P 500, 60: 0.81moved with S&P 500 on 27 of 60 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 8 up · 12 downof 20
Last 60 sessions: 28 up · 31 downof 59
Best session, 250: ▲ +26%May 11
Worst session, 250: ▼ −57%Sep 30

2 headlines on LQDA

latest Oct 1, 2026 · links go to the publisher

Oct 1Liquidia Stock Plunges 57% on UTHR Patent Litigation SetbackZacks Investment Research Oct 1UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%Zacks Investment Research

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 57% of reported volume on Sep 30, 2026, against 66% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume

LQDA daily short-sale volume
Session	Short volume	Reported volume	Short share
Sep 30, 2026	5.99M	10.5M	57.1%
Sep 29, 2026	381K	581K	65.6%
Sep 28, 2026	273K	436K	62.7%
Sep 25, 2026	254K	407K	62.4%
Sep 24, 2026	260K	428K	60.8%
Sep 23, 2026	208K	291K	71.6%
Sep 22, 2026	204K	285K	71.4%
Sep 21, 2026	207K	314K	65.9%
Sep 18, 2026	253K	334K	75.7%
Sep 17, 2026	208K	301K	69.3%

Filings

SEC EDGAR · newest first

LQDA SEC filings
Filed	Form	Report date
Sep 30, 2026	8-K	Sep 30, 2026
Sep 15, 2026	4	Sep 11, 2026
Sep 14, 2026	144	—
Sep 11, 2026	144	—
Sep 3, 2026	4	Sep 1, 2026
Sep 3, 2026	8-K	Sep 3, 2026
Aug 25, 2026	4	Aug 21, 2026
Aug 21, 2026	144	—
Aug 21, 2026	4	Aug 19, 2026
Aug 19, 2026	144	—
Aug 19, 2026	144	—
Aug 19, 2026	4	Aug 17, 2026
Aug 17, 2026	144	—
Aug 14, 2026	SCHEDULE 13G/A	—
Aug 12, 2026	8-K	Aug 12, 2026
Aug 12, 2026	10-Q	Jun 30, 2026
Aug 4, 2026	SCHEDULE 13G/A	—
Jul 29, 2026	4	Jul 27, 2026
Jul 29, 2026	4	Jul 27, 2026
Jul 24, 2026	4	Jul 22, 2026
Jul 22, 2026	4	Jul 20, 2026
Jul 14, 2026	4	Jul 10, 2026
Jul 14, 2026	4	Jul 13, 2026
Jul 14, 2026	4	Jul 10, 2026
Jul 14, 2026	4	Jul 10, 2026

About Liquidia Corporation Common Stock

SEC and exchange records

Company: Liquidia Corporation Common Stock
Exchange: XNAS
Industry: Pharmaceutical Preparations · SEC standard industrial classification
SEC CIK: 1819576
Sessions on record: 131
Price source: End of day · delayed
Computed: 2 Oct, 03:08 am IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.